How much funding has Twist Bioscience raised?

Twist Bioscience has raised $193.1M in total funding, most recently a Extension Round.

Who are Twist Bioscience's investors?

Twist Bioscience's investors include ARCH Venture Partners, Illumina Ventures, Biomatics Capital Partners, Reinet Fund, Nick and Joby Pritzker, Tao Invest.

When was Twist Bioscience founded?

Twist Bioscience was founded in 2013.

Where is Twist Bioscience headquartered?

Twist Bioscience is headquartered in South San Francisco, California, United States.

What industry is Twist Bioscience in?

Twist Bioscience operates in Biotech, Healthcare.

How many employees does Twist Bioscience have?

Twist Bioscience has 1001-5000 employees.

Twist Bioscience

IPO

We lead innovation in DNA synthesis

Public · South San Francisco, United States · Founded 2013 · $193.1M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 1001–5000
Founded: 2013
Business Model: B2B
Website: twistbioscience.com

Total Funding: $193.1M
Last Round: $27.0M Extension RoundJun 2017
Rounds: 6
Type: Public

About

Twist Bioscience developed a proprietary semiconductor-based DNA synthesis platform that miniaturizes chemistry using silicon chips with 10,000 nanowells. The company manufactures synthetic genes, oligo pools, NGS target enrichment kits, variant libraries, and antibody discovery tools. Its products serve researchers across therapeutics, diagnostics, agriculture, data storage, and industrial biotechnology worldwide.

Summary

Twist Bioscience is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $193.1M in total across 6 rounds, most recently a $27.0M Extension Round round in Jun 2017. Investors include ARCH Venture Partners, Illumina Ventures and Biomatics Capital Partners.

LinkedIn X (Twitter)